FBT holdings
First Trust Amex Biotech Index Fund
Positions
32 stored of 32 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CORCEPT THERAPEUTICS INC CORCEPT THERAPEUTICS INC COM | US2183521028 | 218352102 | 5.598% | $157.5M | Equity (common) | Corporate | United States | USD |
| 2 | NEOGENOMICS INC NEOGENOMICS INC COM NEW | US64049M2098 | 64049M209 | 5.120% | $144.0M | Equity (common) | Corporate | United States | USD |
| 3 | VERACYTE INC VERACYTE INC COM | US92337F1075 | 92337F107 | 5.097% | $143.4M | Equity (common) | Corporate | United States | USD |
| 4 | BRUKER CORP BRUKER CORP COM | US1167941087 | 116794108 | 4.320% | $121.5M | Equity (common) | Corporate | United States | USD |
| 5 | ALKERMES PLC ALKERMES PLC SHS | IE00B56GVS15 | Not reported | 4.238% | $119.2M | Equity (common) | Corporate | Ireland | USD |
| 6 | ILLUMINA INC ILLUMINA INC COM | US4523271090 | 452327109 | 3.923% | $110.4M | Equity (common) | Corporate | United States | USD |
| 7 | KRYSTAL BIOTECH INC KRYSTAL BIOTECH INC COM | US5011471027 | 501147102 | 3.872% | $108.9M | Equity (common) | Corporate | United States | USD |
| 8 | NATERA INC NATERA INC COM | US6323071042 | 632307104 | 3.795% | $106.7M | Equity (common) | Corporate | United States | USD |
| 9 | AXSOME THERAPEUTICS INC AXSOME THERAPEUTICS INC COM | US05464T1043 | 05464T104 | 3.708% | $104.3M | Equity (common) | Corporate | United States | USD |
| 10 | NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC COM | US64125C1099 | 64125C109 | 3.528% | $99.2M | Equity (common) | Corporate | United States | USD |
| 11 | BIO-TECHNE CORP BIO-TECHNE CORP COM | US09073M1045 | 09073M104 | 3.432% | $96.5M | Equity (common) | Corporate | United States | USD |
| 12 | ARROWHEAD PHARMACEUTICALS INC ARROWHEAD PHARMACEUTICALS INC COM | US04280A1007 | 04280A100 | 3.376% | $95.0M | Equity (common) | Corporate | United States | USD |
| 13 | BIOGEN INC BIOGEN INC COM | US09062X1037 | 09062X103 | 3.371% | $94.8M | Equity (common) | Corporate | United States | USD |
| 14 | EXELIXIS INC EXELIXIS INC COM | US30161Q1040 | 30161Q104 | 3.316% | $93.3M | Equity (common) | Corporate | United States | USD |
| 15 | INCYTE CORP INCYTE CORP COM | US45337C1027 | 45337C102 | 3.184% | $89.6M | Equity (common) | Corporate | United States | USD |
| 16 | ARGENX SE ARGENX SE SPONSORED ADR | US04016X1019 | 04016X101 | 3.131% | $88.1M | Equity (common) | Corporate | Netherlands | USD |
| 17 | HALOZYME THERAPEUTICS INC HALOZYME THERAPEUTICS INC COM | US40637H1095 | 40637H109 | 3.114% | $87.6M | Equity (common) | Corporate | United States | USD |
| 18 | VERTEX PHARMACEUTICALS INC VERTEX PHARMACEUTICALS INC COM | US92532F1003 | 92532F100 | 3.072% | $86.4M | Equity (common) | Corporate | United States | USD |
| 19 | REPLIGEN CORP REPLIGEN CORP COM | US7599161095 | 759916109 | 3.065% | $86.2M | Equity (common) | Corporate | United States | USD |
| 20 | BIOMARIN PHARMACEUTICAL INC BIOMARIN PHARMACEUTICAL INC COM | US09061G1013 | 09061G101 | 2.831% | $79.6M | Equity (common) | Corporate | United States | USD |
| 21 | AMGEN INC AMGEN INC COM | US0311621009 | 031162100 | 2.784% | $78.3M | Equity (common) | Corporate | United States | USD |
| 22 | BIONTECH SE BIONTECH SE SPONSORED ADS | US09075V1026 | 09075V102 | 2.629% | $73.9M | Equity (common) | Corporate | Germany | USD |
| 23 | GENMAB A/S GENMAB A/S SPONSORED ADS | US3723032062 | 372303206 | 2.624% | $73.8M | Equity (common) | Corporate | Denmark | USD |
| 24 | UNITED THERAPEUTICS CORP UNITED THERAPEUTICS CORP COM | US91307C1027 | 91307C102 | 2.557% | $71.9M | Equity (common) | Corporate | United States | USD |
| 25 | ALNYLAM PHARMACEUTICALS INC ALNYLAM PHARMACEUTICALS INC COM | US02043Q1076 | 02043Q107 | 2.522% | $70.9M | Equity (common) | Corporate | United States | USD |
| 26 | BEONE MEDICINES LTD BEONE MEDICINES LTD SPONSORED ADS | US07725L1026 | 07725L102 | 2.483% | $69.8M | Equity (common) | Corporate | Switzerland | USD |
| 27 | GILEAD SCIENCES INC GILEAD SCIENCES INC COM | US3755581036 | 375558103 | 2.452% | $69.0M | Equity (common) | Corporate | United States | USD |
| 28 | ADMA BIOLOGICS INC ADMA BIOLOGICS INC COM | US0008991046 | 000899104 | 2.328% | $65.5M | Equity (common) | Corporate | United States | USD |
| 29 | SAREPTA THERAPEUTICS INC SAREPTA THERAPEUTICS INC COM | US8036071004 | 803607100 | 2.289% | $64.4M | Equity (common) | Corporate | United States | USD |
| 30 | REGENERON PHARMACEUTICALS INC REGENERON PHARMACEUTICALS INC COM | US75886F1075 | 75886F107 | 2.247% | $63.2M | Equity (common) | Corporate | United States | USD |
| 31 | DREYFUS GOVERNMENT CASH MANAGEMENT FUNDS DREYFUS GOVERNMENT CASH MANAGEMENT FUNDS SH BEN INT | US2620062081 | 262006208 | 0.054% | $1.5M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 32 | DAIWA CAPITAL MARKETS AMERICA INC. | Not reported | Not reported | <0.001% | $5K | Repurchase agreements | Corporate | United States | USD |